6ppd-q

Intervention1 paper2 findings

C · W · M · H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper that declares the maker’s interest.

1 lab in 1 country

Funders: National Natural Science Foundation of China and 2 more

  • Humans1

Outcomes

1

Cognitive function

downin humans1

1 study
  1. 6ppd-q impairs cognitive function in humans.

    Humans

    Aromatic amine antioxidants (AAs) and p-phenylenediamine quinones (PPD-Qs) exposure, thyroid hormones, and cognitive function in older adults: Association and potential mediation analyses · Environment international · 30 Aug 2026

Associations

1

Cognitive impairment

upin humans1

1 study
  1. 6ppd-q raises the risk of cognitive impairment in humans.

    Humans

    Aromatic amine antioxidants (AAs) and p-phenylenediamine quinones (PPD-Qs) exposure, thyroid hormones, and cognitive function in older adults: Association and potential mediation analyses · Environment international · 30 Aug 2026

Cognitive impairment →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01